This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Hepatitis is an inflammation of the liver caused by a virus or toxin. It can be acute or chronic and is one of the leading causes of death around the world. Diagnosis of hepatitis can be difficult, as the symptoms may be vague or non-specific. Clinical presentation may include jaundice, nausea, vomiting, abdominal pain, malaise, and fatigue. Laboratory testing is necessary to confirm the diagnosis and to distinguish between the different forms of hepatitis. Epidemiology is the study of the occurrence, cause, and distribution of disease in a population. It can be used to identify risk factors, understand the natural history of a disease, and evaluate the efficacy of interventions. For hepatitis, epidemiology can be used to identify high risk groups and to determine the prevalence of the disease in specific populations. Serologic testing is the most common method used to diagnose hepatitis. These tests measure the presence of antibodies to the virus in the blood. Enzyme-linked immunosorbent assay (ELISA) is a common type of serological test used to detect antibodies to hepatitis A, B, and C. Other tests such as polymerase chain reaction (PCR) and antigen testing may also be used. Imaging tests such as ultrasound and magnetic resonance imaging (MRI) can also be used to diagnose hepatitis. These tests can detect structural changes in the liver and can be used to distinguish between different forms of hepatitis. In addition to serology and imaging, a liver biopsy is sometimes used to diagnose hepatitis. This involves taking a small sample of the liver tissue and examining it under a microscope. A biopsy can provide valuable information about the extent of damage to the liver caused by hepatitis and can help differentiate between different forms of the disease. Epidemiological studies can provide important information about the prevalence of hepatitis in different populations, as well as the risk factors associated with the disease. These studies can help inform public health policies and develop strategies to prevent and control the spread of hepatitis.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States